secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2023-02-23T23:59:59+00:00
Accession:  0001731122-23-000258
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enochian BioSciences receives Nasdaq notice for delayed Form 10-Q filing and amends convertible notes
--------------------------------------------------------------------------------

- Amended and restated two $600,000 convertible notes with Paseco ApS, extending maturity to February 28, 2024 and securing obligations.
- Amended a $5,000,000 promissory note from March 2020 to secure obligations under a new security agreement.
- Entered into a security agreement granting Paseco ApS a first priority security interest in all of Enochian's assets.
- Received Nasdaq notice on February 16, 2023 for non-compliance due to delayed filing of Form 10-Q for period ended December 31, 2022.
- Nasdaq previously accepted compliance plan; deadline to regain compliance is April 11, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112223000258/0001731122-23-000258-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112223000258/e4441_8k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-23-000258

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer